Keywords: gsk, licenses, rights, scios, natrecor, glaxosmithkline, says
GSK licenses rights to Scios' Natrecor
Article | 14 January 2002
GlaxoSmithKline says it has entered into a European licensing agreementwith the USA's Scios for the latter's Natrecor (nesiritide), a treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
